Figure 2. Forest plot of prolonged anosmia and fatigue in COVID-19 survivors. (A) Estimated prevalence of prolonged anosmia in COVID-19 survivor (event rate: 9.7%, 95%CI: 6.1%–15.2%, p<0.001, p Egger 0.577, p heterogeneity <0.0001. (B) Estimated prevalence of prolonged fatigue in COVID-19 survivor (event rate: 21.2%, 95%CI: 11.9%–34.8%, p<0.001, p Egger: 1.254, p heterogeneity <0.0001.
